RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY-Reference-Cited by-同舟云学术

RENAL CELL CARCINOMA 2005: NEW FRONTIERS IN STAGING, PROGNOSTICATION AND TARGETED MOLECULAR THERAPY

Published:2005-06 Issue:6 Volume:173 Page:1853-1862
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

LAM JOHN S.¹,SHVARTS OLEG¹,LEPPERT JOHN T.¹,FIGLIN ROBERT A.¹,BELLDEGRUN ARIE S.¹

Affiliation:

1. From the Departments of Urology (JSL, OS, JTL, RAF, ASB), and Medicine (RAF), David Geffen School of Medicine at University of California-Los Angeles, Los Angeles, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference68 articles.

1. Cancer Statistics, 2004

2. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

3. Cytokine-based therapy for metastatic renal cell cancer

4. Searching for the hereditary causes of renal-cell carcinoma

5. TNM staging of renal cell carcinoma

Cited by 301 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Resected Case of Simultaneous Gastric and Multiple Pancreatic Metastases of Renal Cell Carcinoma 11 Years After Nephrectomy;Cureus;2024-09-10

2. Natural small-molecules reverse Xeroderma Pigmentosum Complementation Group C (XPC) deficient-mediated drug-resistance in renal cell carcinoma;Phytomedicine;2024-02

3. A case report of liver infiltration from a large renal cell carcinoma: Diagnostic and management enigma;International Journal of Surgery Case Reports;2024-01

4. PAK5 potentiates slug transactivation of N-cadherin to facilitate metastasis of renal cell carcinoma;Cellular Signalling;2023-10

5. Adrenal Metastases Are Associated with Poor Outcomes in Patients with Metastatic Clear Cell Renal Cell Carcinoma Treated with Nivolumab in the GETUG-AFU-26 NIVOREN Phase 2 Trial;European Urology Oncology;2023-10